Showing 1 - 7 results of 7 for search 'Maria Ochoa-de-Olza', query time: 1.67s Refine Results
  1. 1
    A promising platform for predicting toxicity

    A promising platform for predicting toxicity by Maria Ochoa de Olza

    Published 2021-09-01
    Get full text
    Article
  2. 2
    Low-dose irradiation for reversing immunotherapy resistance: how to translate?

    Low-dose irradiation for reversing immunotherapy resistance: how to translate? by María Ochoa-de-Olza, Jean Bourhis, Fernanda G Herrera

    Published 2022-07-01
    Get full text
    Article
  3. 3
    Tumor-Associated Microbiome: Where Do We Stand?

    Tumor-Associated Microbiome: Where Do We Stand? by Marc Oliva, Nuria Mulet-Margalef, Maria Ochoa-De-Olza, Stefania Napoli, Joan Mas, Berta Laquente, Laia Alemany, Eric J. Duell, Paolo Nuciforo, Victor Moreno

    Published 2021-02-01
    Get full text
    Article
  4. 4
    Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer

    Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer by Vicenç Ruiz de Porras, Vicenç Ruiz de Porras, Vicenç Ruiz de Porras, Adrià Bernat-Peguera, Adrià Bernat-Peguera, Clara Alcon, Fernando Laguia, Maria Fernández-Saorin, Maria Fernández-Saorin, Natalia Jiménez, Ana Senan-Salinas, Ana Senan-Salinas, Carme Solé-Blanch, Carme Solé-Blanch, Andrea Feu, Mercedes Marín-Aguilera, Juan Carlos Pardo, Juan Carlos Pardo, Juan Carlos Pardo, Maria Ochoa-de-Olza, Maria Ochoa-de-Olza, Maria Ochoa-de-Olza, Joan Montero, Begoña Mellado, Begoña Mellado, Albert Font, Albert Font, Albert Font

    Published 2024-01-01
    Get full text
    Article
  5. 5
    Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

    Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients by Gabriela Jiménez-Valerio, Mar Martínez-Lozano, Nicklas Bassani, August Vidal, María Ochoa-de-Olza, Cristina Suárez, Xavier García-del-Muro, Joan Carles, Francesc Viñals, Mariona Graupera, Stefano Indraccolo, Oriol Casanovas

    Published 2016-05-01
    Get full text
    Article
  6. 6
    A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

    A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer by Ernest Nadal, Mansoor Saleh, Santiago Ponce Aix, Maria Ochoa-de-Olza, Sandip Pravin Patel, Scott Antonia, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Shawn T. Estrem, Jiangang Liu, Emin Avsar, Wen Hong Lin, Karim A. Benhadji, Leena Gandhi, Susan C. Guba, Inmaculada Ales Diaz

    Published 2023-07-01
    Get full text
    Article
  7. 7
    Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery

    Prognostic Role of Neutrophil, Monocyte and Platelet to Lymphocyte Ratios in Advanced Ovarian Cancer According to the Time of Debulking Surgery by Andrea Plaja, Iris Teruel, Maria Ochoa-de-Olza, Marc Cucurull, Álvaro Javier Arroyo, Beatriz Pardo, Irene Ortiz, Marta Gil-Martin, Josep María Piulats, Helena Pla, Claudia Fina, Anna Carbó, Maria-Pilar Barretina-Ginesta, Sergio Martínez-Román, Elvira Carballas, Andrea González, Anna Esteve, Margarita Romeo

    Published 2023-07-01
    Get full text
    Article

Search Tools: